Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis

Exp Dermatol. 2023 Jul;32(7):1162-1164. doi: 10.1111/exd.14822. Epub 2023 Apr 26.

Authors

F Rosset¹, L Mastorino¹, P Dapavo¹, P Quaglino¹, S Ribero¹

Affiliation

¹ Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.

PMID: 37098693
DOI: 10.1111/exd.14822

No abstract available

Keywords: PASI; biologics; comorbidities; frail patients; psoriasis.

Publication types

Letter

MeSH terms

Aged
Biological Products*
Biological Therapy
Comorbidity
Frail Elderly
Humans
Psoriasis* / drug therapy
Psoriasis* / epidemiology
Severity of Illness Index
Treatment Outcome
Ustekinumab

Substances

Ustekinumab
Biological Products